GO:0002387 immune response in gut-associated lymphoid tissue: Microbiota-Driven Immunity, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0002387 describes the immune response that takes place specifically within gut-associated lymphoid tissue (GALT), which includes Peyer's patches, the appendix, and solitary lymph nodules.
• GALT is a microbiota-driven hub of B cell immunity, where commensal signals shape germinal center reactions, IgA class switching, and plasma cell survival.
• Human GALT is structurally diverse, comprising organized inductive sites (Peyer's patches, isolated lymphoid follicles) and diffuse effector sites in the lamina propria.
• Microbiota composition dynamically modulates immune cell populations and drives structural remodeling of GALT throughout life.
• Dysregulated GALT immune responses are implicated in inflammatory bowel disease (IBD), where intestinal microbiota and GALT immunity contribute to chronic inflammation.
• Comparative and single-cell atlases of GALT reveal conserved and species-specific B cell diversification mechanisms relevant to vaccine and therapeutic design.
Description
The Gene Ontology term GO:0002387, immune response in gut-associated lymphoid tissue, defines the immune response taking place in the gut-associated lymphoid tissue (GALT). GALT is a specialized collection of lymphoid structures in the intestinal tract that includes Peyer's patches, the appendix, and solitary lymph nodules. This term captures the unique immunological environment of the gut, where the host must balance tolerance to commensal microbiota with defense against pathogens. Understanding GO:0002387 is essential for researchers studying mucosal immunity, vaccine development, and inflammatory bowel disease, as GALT is the primary site where intestinal immune responses are initiated and regulated. The GALT immune response is not a static process; it is continuously shaped by microbial signals that drive B cell diversification, germinal center formation, and IgA production. Recent single-cell and spatial atlases have begun to resolve the cellular heterogeneity of human GALT, revealing immunomodulatory interactions between B cells and other immune populations. This article provides a research-grade overview of GO:0002387, covering its definition, biological mechanisms, key genes, disease relevance, and experimental models for CRISPR-based interrogation.
immune response in gut-associated lymphoid tissue At A Glance
| GO ID | GO:0002387 |
|---|---|
| GO term | immune response in gut-associated lymphoid tissue |
| Ontology | biological_process |
| Synonym | immune response in GALT |
| Definition | Immune response taking place in the gut-associated lymphoid tissue (GALT). GALT includes Peyer's patches, appendix, and solitary lymph nodules. |
| Major function | Coordination of innate and adaptive immune responses in intestinal lymphoid structures, including antigen sampling, germinal center reactions, and IgA production. |
| Anatomical locations | Peyer's patches, appendix, solitary lymph nodules, isolated lymphoid follicles, and lamina propria effector sites. |
| Key cell types | B cells, T cells, dendritic cells, macrophages, innate lymphoid cells, and M cells. |
| Physiological triggers | Commensal microbiota, dietary antigens, and pathogenic infection. |
What Is GO:0002387?
GO:0002387 is a biological process term defined as the immune response taking place in the gut-associated lymphoid tissue (GALT). GALT includes Peyer's patches, the appendix, and solitary lymph nodules. The synonym immune response in GALT is used interchangeably. This term encompasses all immune reactions—innate and adaptive—that occur within these specialized intestinal lymphoid structures, distinguishing them from systemic immune responses.
Why Is immune response in gut-associated lymphoid tissue Important in Cell Biology?
GO:0002387 is critically important because GALT is the largest immune organ in the body and serves as the primary interface between the host and the dense microbial communities of the intestine. The immune response in GALT determines whether the host mounts a protective response against pathogens or maintains tolerance to harmless commensals. Disruption of this balance is a central mechanism in inflammatory bowel disease and other intestinal disorders. Furthermore, GALT is the site of B cell diversification and IgA class switching, processes that are essential for mucosal barrier function and have been co-opted for vaccine design. Understanding the molecular and cellular players in GO:0002387 is therefore fundamental to immunology, gastroenterology, and translational medicine.
• GALT is the largest immune organ and the first line of defense against intestinal pathogens.
• The immune response in GALT is microbiota-driven and shapes systemic immune homeostasis.
• Dysregulation of GALT immunity is a hallmark of inflammatory bowel disease (IBD).
• GALT is the primary site of IgA class switching and B cell diversification, critical for mucosal vaccines.
• Microbiota-induced structural changes in GALT affect immune cell populations throughout life.
• Human GALT atlases reveal immunomodulatory interactions that can be targeted therapeutically.
• Comparative studies of GALT across species inform evolutionary and developmental immunology.
• GALT dysfunction has been linked to neurodevelopmental and neurological disorders through the gut-brain axis.
• Understanding GALT immune responses aids in designing oral vaccines and immunotherapies.
• CRISPR-based models of GALT genes enable causal dissection of mucosal immunity.
What Happens During immune response in gut-associated lymphoid tissue?
Antigen Sampling and Presentation
In simple terms: The gut samples bits of bacteria and food to decide whether to attack or tolerate them.
The immune response in GALT begins with antigen sampling by specialized epithelial cells called M cells, which transport luminal antigens to underlying dendritic cells and macrophages in Peyer's patches and isolated lymphoid follicles. Dendritic cells then process and present antigens to naive T and B cells, initiating adaptive immune responses. This step is heavily influenced by the commensal microbiota, which provides continuous low-level stimulation that maintains GALT architecture and function.
Germinal Center Formation and B Cell Diversification
In simple terms: B cells undergo training in specialized zones to produce better antibodies.
Upon antigen encounter, B cells in GALT form germinal centers where they undergo somatic hypermutation and class switch recombination, leading to the production of high-affinity IgA antibodies. This process is driven by microbiota-derived signals and is a hallmark of GALT immunity. B cell diversification mechanisms in GALT show species-specific features, from birds to humans, highlighting conserved and divergent pathways. Recent human GALT atlases have revealed immunomodulatory interactions of B cells with other immune populations in these germinal centers.
IgA Class Switching and Plasma Cell Differentiation
In simple terms: B cells become antibody factories that secrete IgA into the gut.
Following germinal center reactions, B cells differentiate into IgA-secreting plasma cells that migrate to the lamina propria. IgA is transported across the epithelium to form a barrier that neutralizes pathogens and toxins without triggering inflammation. This process is dependent on cytokines such as TGF-beta and retinoic acid, and is modulated by the microbiota. The appendix and solitary lymph nodules also contribute to IgA production and plasma cell survival.
Microbiota-Driven Structural Remodeling
In simple terms: Gut bacteria constantly reshape the immune structures in the gut.
The microbiota is not a passive bystander; it actively drives dynamic structural changes in GALT, including the size and cellularity of Peyer's patches and isolated lymphoid follicles. Germ-free animals exhibit underdeveloped GALT, and microbial colonization restores its structure and function. This remodeling ensures that the immune response remains adaptable to changes in the microbial environment and is critical for maintaining homeostasis.
Effector and Regulatory T Cell Responses
In simple terms: T cells help control inflammation and tolerance in the gut.
GALT contains a balance of effector T cells (Th1, Th17) and regulatory T cells (Tregs) that together determine the outcome of immune responses. Tregs are essential for suppressing inappropriate reactions to commensals, while effector T cells combat pathogens. The microbiota influences this balance, and disruption can lead to inflammatory pathology. This regulatory network is a key component of GO:0002387 and a target for therapeutic intervention in IBD.
Key Genes Involved in GO:0002387 immune response in gut-associated lymphoid tissue
The following genes and proteins are central to the immune response in gut-associated lymphoid tissue (GO:0002387), based on their established roles in GALT development, B cell diversification, IgA production, and microbiota sensing.
| Gene | Major Role | Research Relevance |
|---|---|---|
| AICDA | Enzyme required for somatic hypermutation and class switch recombination in germinal center B cells | Knockout models show defective IgA production and GALT germinal centers |
| TNFRSF13B | Transmembrane activator and CAML interactor (TACI) for IgA class switching | Mutations linked to common variable immunodeficiency and GALT dysfunction |
| CD40 | Costimulatory receptor on B cells for T-dependent activation | CD40 knockout mice have impaired GALT germinal centers |
| CD40LG | Ligand for CD40 on activated T cells | Defects cause hyper-IgM syndrome with GALT abnormalities |
| IL6 | Cytokine promoting plasma cell survival and IgA secretion | IL6 blockade affects GALT plasma cell niches |
| TGFB1 | Cytokine driving IgA class switching and Treg induction | TGFB1 knockout mice display severe intestinal inflammation |
| RETNLB | Resistin-like molecule beta produced by goblet cells, promotes M cell differentiation | Knockout impairs antigen sampling in Peyer's patches |
| CCL20 | Chemokine recruiting CCR6+ immune cells to GALT | CCL20-CCR6 axis is critical for GALT organization |
| LTBR | Lymphotoxin beta receptor for lymphoid tissue organizer signaling | LTBR knockout mice lack Peyer's patches and lymph nodes |
| RORC | Transcription factor for innate lymphoid cells and Th17 cells | RORC mutations affect GALT lymphoid tissue inducer cells |
| FOXP3 | Master regulator of regulatory T cells | FOXP3 deficiency causes IPEX with severe gut inflammation |
| NOD2 | Intracellular sensor of bacterial muramyl dipeptide | NOD2 variants are risk factors for Crohn's disease |
| MYD88 | Adaptor for TLR signaling in innate immune cells | MYD88 knockout mice have impaired GALT IgA responses |
| BATF | Transcription factor for germinal center B cells and plasma cells | BATF is required for GALT plasma cell differentiation |
| PRDM1 | Blimp-1, transcription factor for plasma cell differentiation | PRDM1 knockout blocks IgA plasma cell formation |
| XBP1 | Transcription factor for plasma cell secretory machinery | XBP1 deletion impairs IgA secretion in GALT |
| IRF4 | Transcription factor for B cell differentiation and class switching | IRF4 is essential for GALT germinal center responses |
How Is immune response in gut-associated lymphoid tissue Regulated?
The immune response in GALT is regulated at multiple levels. Microbiota-derived signals through pattern recognition receptors (e.g., TLRs, NOD2) activate NF-kB and MAPK pathways, driving cytokine production and cellular activation. Cytokines such as TGF-beta, IL-6, and retinoic acid control IgA class switching and Treg/Th17 balance. Transcription factors including IRF4, PRDM1, and XBP1 orchestrate plasma cell differentiation. Additionally, the lymphotoxin-beta receptor pathway is essential for the development and maintenance of GALT structures. Dysregulation of these pathways can lead to chronic inflammation, as seen in IBD.
immune response in gut-associated lymphoid tissue and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NOD2 | Crohn's disease, impaired bacterial sensing in GALT | NOD2 knockout intestinal organoids or mice |
| TNFRSF13B | Common variable immunodeficiency, defective IgA class switching | TNFRSF13B knockout B cell lines or mice |
| FOXP3 | IPEX syndrome, severe gut inflammation due to Treg deficiency | FOXP3 knockout mice or human iPSC-derived Tregs |
| AICDA | Hyper-IgM syndrome, defective germinal center reactions | AICDA knockout mice or Ramos B cell line |
| IL6 | IBD, plasma cell survival and inflammation | IL6 knockout mice or intestinal organoids |
Inflammatory Bowel Disease (IBD)
IBD, including Crohn's disease and ulcerative colitis, is characterized by chronic inflammation of the gastrointestinal tract. The aetiology involves an inappropriate immune response in GALT to the intestinal microbiota. Genetic variants in NOD2, which senses bacterial components, are strongly associated with Crohn's disease, highlighting the role of GALT innate immunity. Dysregulated T cell responses and impaired regulatory T cell function in GALT contribute to tissue damage. Targeting GALT immune pathways is a major therapeutic strategy in IBD.
Common Variable Immunodeficiency (CVID)
CVID is a primary immunodeficiency often characterized by defective B cell differentiation and low IgA levels. Mutations in TNFRSF13B (TACI) and other genes involved in GALT B cell responses lead to impaired IgA production and recurrent infections. GALT germinal center dysfunction is a key feature in CVID patients, making it a relevant disease model for GO:0002387.
Neurodevelopmental and Neurological Disorders
Emerging evidence links GALT dysfunction to neurodevelopmental and neurological disorders through the gut-brain axis. Alterations in GALT immune responses can affect brain development and behavior, as reviewed in the context of patchy tissues. This connection underscores the systemic importance of GO:0002387 beyond the gut.
From immune response in gut-associated lymphoid tissue-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate IgA class switching in GALT? | Knockout of gene X in mice or human B cell lines, followed by IgA ELISA |
| Does a point mutation in gene Y affect germinal center formation? | Point-mutation knock-in mice or CRISPR-edited organoids |
| Can a tagged version of protein Z reveal its localization in GALT? | Tagged knock-in (e.g., GFP) in mice or human intestinal organoids |
| Does overexpression of gene W enhance mucosal immunity? | Overexpression transgenic mice or lentiviral transduction of GALT cells |
| What is the role of gene V in microbiota-driven GALT remodeling? | Germ-free mice colonized with defined microbiota, with gene V knockout |
| Can CRISPR library screening identify novel regulators of GALT immune response? | Pooled CRISPR knockout library in primary GALT B cells or organoids |
How to Study the immune response in gut-associated lymphoid tissue Process
| Method | What It Measures | Typical Application |
|---|---|---|
| scRNA-seq | Transcriptomes of individual cells in GALT | Identifying immune cell subsets and states |
| Spatial transcriptomics | Gene expression with spatial context in GALT tissue | Mapping cellular interactions in Peyer's patches |
| Immunohistochemistry | Protein localization and tissue architecture | Visualizing GALT structures and immune cells |
| Germ-free/gnotobiotic models | Effect of microbiota on GALT development and function | Causal testing of microbial signals |
| CRISPR knockout screening | Gene function in immune cells | Discovery of novel regulators of GALT immunity |
| IgA ELISA | Secreted IgA levels in feces or serum | Assessing mucosal humoral immunity |
| Flow cytometry | Immune cell populations and activation states | Quantifying B and T cell subsets in GALT |
| Organoid culture | Epithelial-immune interactions in vitro | Modeling GALT immune responses |
Single-Cell RNA Sequencing and Spatial Transcriptomics
Single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics have been used to create atlases of human GALT, revealing cellular heterogeneity and immunomodulatory interactions of B cells. These methods allow researchers to identify distinct cell populations and their spatial organization within Peyer's patches and other GALT structures. They are essential for understanding the complex cellular dynamics of GO:0002387.
Immunohistochemistry and Imaging
Immunohistochemistry (IHC) and immunofluorescence are classic methods for visualizing GALT structures and immune cell subsets in tissue sections. Lauriano et al. used IHC to characterize GALT in African bonytongue, demonstrating the conserved nature of these structures. In human studies, multiplex imaging can reveal the spatial distribution of B cells, T cells, and dendritic cells in GALT.
Microbiota Manipulation and Gnotobiotic Models
Germ-free and gnotobiotic animal models are invaluable for studying how microbiota drive GALT immune responses. Colonization of germ-free mice with specific microbial communities induces structural and functional changes in GALT. These models help establish causal relationships between microbiota and GO:0002387.
CRISPR Screening and Functional Genomics
Pooled CRISPR knockout screens in primary immune cells or organoids can identify genes that regulate GALT immune responses. For example, screening in B cells can uncover novel regulators of IgA class switching or germinal center formation. This approach is powerful for unbiased discovery of genes involved in GO:0002387.
How CRISPR Can Be Used to Study GO:0002387 immune response in gut-associated lymphoid tissue
Knockout
CRISPR knockout (KO) of genes such as AICDA, NOD2, or TNFRSF13B in mice or human cell lines can reveal their essential roles in GALT immune responses. For example, AICDA KO abolishes IgA class switching, leading to defective mucosal immunity. KO models are foundational for establishing causality in GO:0002387 research.
Point Mutation
Point mutations identified in patients (e.g., NOD2 variants in Crohn's disease) can be introduced into cell lines or mice using CRISPR base editing or homology-directed repair. These models help determine whether specific variants are pathogenic and how they affect GALT function. Point-mutation knock-in models are particularly useful for studying gene-disease links.
Knock-in
Knock-in of reporter tags (e.g., GFP) or human disease alleles into the endogenous locus allows tracking of protein expression and function in GALT. For instance, tagging IRF4 or PRDM1 can reveal their dynamics during plasma cell differentiation. Knock-in models are valuable for understanding spatial and temporal aspects of GALT immunity.
Overexpression
Overexpression of genes such as IL6 or TGFB1 in GALT cells can model chronic inflammation or enhanced IgA production. CRISPR activation (CRISPRa) or transgenic approaches enable gain-of-function studies to complement KO experiments. Overexpression models help identify sufficiency of a gene in driving GALT immune responses.
How EDITGENE Supports immune response in gut-associated lymphoid tissue Research
Researchers studying immune response in gut-associated lymphoid tissue-related genes often need to determine whether a candidate gene is causally involved in GALT development, IgA production, or inflammatory pathology. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models and animal models, enabling rigorous functional validation of genes implicated in GO:0002387.
Contact EDITGENE today to design your custom CRISPR model for immune response in gut-associated lymphoid tissue research.
Frequently Asked Questions About immune response in gut-associated lymphoid tissue
What is GO:0002387?
GO:0002387 is the Gene Ontology term for immune response in gut-associated lymphoid tissue (GALT). It describes the immune reactions occurring in Peyer's patches, appendix, and solitary lymph nodules.
What is gut-associated lymphoid tissue (GALT)?
GALT is a collection of lymphoid structures in the gut, including Peyer's patches, appendix, and solitary lymph nodules, that initiate and regulate immune responses to intestinal antigens and microbiota.
What genes are involved in immune response in gut-associated lymphoid tissue?
Key genes include AICDA, TNFRSF13B, CD40, IL6, TGFB1, NOD2, MYD88, and transcription factors like IRF4, PRDM1, and XBP1, which regulate B cell diversification, IgA class switching, and germinal center formation.
How does the microbiota influence GALT immunity?
The microbiota provides continuous signals that drive GALT development, germinal center reactions, and IgA production. Germ-free animals have underdeveloped GALT, and microbial colonization restores its structure and function.
What diseases are associated with GALT dysfunction?
Inflammatory bowel disease (IBD), common variable immunodeficiency (CVID), and certain neurodevelopmental disorders have been linked to dysregulated GALT immune responses.
How can I study GO:0002387 in the lab?
Common methods include single-cell RNA sequencing, spatial transcriptomics, immunohistochemistry, germ-free models, and CRISPR screening in immune cells or organoids.
What is the role of IgA in GALT immunity?
IgA is the main antibody produced in GALT. It neutralizes pathogens and toxins in the gut lumen without causing inflammation, and its production depends on class switching in germinal center B cells.
Can CRISPR be used to model GALT-related diseases?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models can recapitulate genetic defects seen in IBD, CVID, and other GALT-associated diseases.
What are Peyer's patches?
Peyer's patches are organized lymphoid follicles in the small intestine that are major inductive sites for GALT immune responses, including antigen sampling and germinal center formation.
Why is GO:0002387 important for vaccine development?
Understanding GALT immunity is crucial for oral vaccine design, as vaccines must induce protective IgA responses in GALT while avoiding tolerance.
Conclusion
GO:0002387, immune response in gut-associated lymphoid tissue, represents a vital biological process at the interface of the host and its microbiota. It encompasses antigen sampling, B cell diversification, IgA class switching, and regulatory T cell responses within specialized structures like Peyer's patches and the appendix. Dysregulation of this process underlies major diseases such as IBD and immunodeficiency, making it a key target for therapeutic intervention. Advances in single-cell atlases and CRISPR technologies are accelerating our understanding of GALT immunity. EDITGENE provides comprehensive CRISPR services to support functional studies of genes involved in GO:0002387, from knockout to knock-in and library screening.
References
- 1. Bemark M et al.. 2024. Gut-associated lymphoid tissue: a microbiota-driven hub of B cell immunity.. Trends Immunol 45(3):211-223 PMID: 38402045
- 2. Mörbe UM et al.. 2021. Human gut-associated lymphoid tissues (GALT); diversity, structure, and function.. Mucosal Immunol 14(4):793-802 PMID: 33753873
- 3. Jan P et al.. 2025. Microbiota modulate immune cell populations and drive dynamic structural changes in gut-associated lymphoid tissue.. Gut Microbes 17(1):2543908 PMID: 40802565
- 4. Thompson-Chagoyán OC et al.. 2005. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.. Clin Nutr 24(3):339-52 PMID: 15896420
- 5. Lauriano ER et al.. 2023. Immunohistochemistry of the Gut-Associated Lymphoid Tissue (GALT) in African Bonytongue (Heterotis niloticus, Cuvier 1829).. Int J Mol Sci 24(3) PMID: 36768639
- 6. Weill JC et al.. 2023. B cell diversification in gut-associated lymphoid tissues: From birds to humans.. J Exp Med 220(11) PMID: 37824081
- 7. Pitcher MJ et al.. 2026. Atlas of human gut-associated lymphoid tissue reveals immunomodulatory interactions of B cells.. Sci Immunol 11(120):eady8948 PMID: 42247482
- 8. Abo-Shaban T et al.. 2023. Issues for patchy tissues: defining roles for gut-associated lymphoid tissue in neurodevelopment and disease.. J Neural Transm (Vienna) 130(3):269-280 PMID: 36309872
